Eudravigilance Gateway News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eudravigilance gateway. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eudravigilance Gateway Today - Breaking & Trending Today

Register to make submissions to the MHRA


Register to make submissions to the MHRA
Submissions related to human medicines need to be submitted directly to the MHRA.
From:
Contents
Print this page
For applications that you plan to submit to the UK (for example, a Marketing Authorisation for the UK or GB market), you will need to submit the information through our national portals. For those regulatory submissions made through European procedures you will need to continue to submit via the EU portals (for example, CESP).
The information on how to make submissions to the MHRA is for the following groups:
all pharmaceutical companies involved in making medicines regulatory submissions and vigilance activities for UK/GB licences ....

United Kingdom , Northern Ireland , European Medicines Agency , Customer Services Centre , Marketing Authorisation , Initial Applications , Substantial Amendments , Trial Notifications , Developmental Safety Update Reports , Eudravigilance Gateway , Getting Started , Reference Guide , User Reference Guide , Gaining Access , Product Licensing , Great Britain , Marketing Authorisation Holder , Investigation Plans , Gateway Management , Authorisation Holders , Marketing Authorisation Holders , European Medicines , Continuity Plan , Trade Association , ஒன்றுபட்டது கிஂக்டம் , வடக்கு ஐயர்ல்யாஂட் ,

Guidance on submitting clinical trial safety reports


Guidance on submitting clinical trial safety reports
How to submit Suspected Unexpected Serious Adverse Drug Reactions (SUSARs) and annual safety reports Development Safety Update Reports (DSURs).
From:
Print this page
You must submit SUSARs in Great Britain and in Northern Ireland to the MHRA in one of the following ways:
If you intend to submit SUSARs using one of the new reporting routes, you must register.
For trials ongoing in both the UK and in European member states dual reporting is needed. You will need to report each SUSAR to both the MHRA and relevant member states, as well as to the European Medicines Agency’s (EMA’s) Eudravigilance Clinical Trial Module (EVCTM). ....

United Kingdom , Northern Ireland , Development Safety Update , Development Safety Update Reports Dsurs , European Medicines Agency , Contract Research Organisations Cros , Customer Services Centre , Great Britain , Eudravigilance Clinical Trial Module , Contract Research Organisations , Eudravigilance Gateway , Gaining Access , Continuity Plan , Business Continuity Plan , Development Safety Update Reports , Annual Progress Reports , Human Medicines , Development Safety Update Report , Regulatory Activity , Original Submission , ஒன்றுபட்டது கிஂக்டம் , வடக்கு ஐயர்ல்யாஂட் , வளர்ச்சி பாதுகாப்பு புதுப்பிப்பு , ஒப்பந்த ஆராய்ச்சி ஆர்கநைஸேஶந்ஸ் கிராஸ் , வாடிக்கையாளர் சேவைகள் மையம் , நன்று பிரிட்டன் ,